|
Post by JHam on Jan 29, 2015 8:21:41 GMT
Lol... Hours after I sold my position of APRI 60% pre market . That's life I guess. Lets hope it was worth the move! Ouch. That sucks. It happens though...
|
|
|
Post by RLC on Jan 29, 2015 14:18:35 GMT
Lol... Hours after I sold my position of APRI 60% pre market . That's life I guess. Lets hope it was worth the move! Ouch. That sucks. It happens tough... Haha... Ya I could probably depress you with the money I've left on the table in my investing career. It definitely happens. It seems like you have the right outlook on it though Yelk. Good luck with OXGN! I thought about opening a small position there on Tuesday but I just haven't done enough research to justify me placing any money here. Will likely look it over this weekend and might make a small purchase early next week.
|
|
|
Post by lcd on Feb 10, 2015 17:04:59 GMT
I distractedly listened to the BIOCEO Oxigene presentation while working this morning and nothing excited me. They are meeting with the FDA in Q2 to discuss ovarian cancer trial and target Q3 to start their AML study and in Q4 complete P2 GI-NET study enrollment that might include results since it is open label. They are expecting feedback from the FDA in Q2 so that is the closest catalyst I can see to take the stock back up over $2.
|
|
|
Post by Yelk on Feb 11, 2015 0:53:08 GMT
My position is almost non existent in this. If all goes well with current Feb/March stocks I will make it at least meaningful just because of the limited apparent downside. Better than having just sitting in cash.
|
|
|
Post by lcd on Feb 11, 2015 14:12:24 GMT
It looks like Alpha Capital Anstalt sold out most of their OXGN holdings. I didn't confirm it myself but someone on twitter said it dropped from almost 9% to under 2%. A major sell off by an institutional investor is rarely a good indicator so I might sell my small holding at a significant loss (@20%) this week. Hopefully I can make it back in a company with more near term catalysts (like ATHX and CUR). www.sec.gov/Archives/edgar/data/908259/000121390015000897/0001213900-15-000897-index.htm
|
|